Form D · Biotechnology
Maximum Fidelity Surgical Simulations, Inc.
St. Louis, MO · CIK 0002037945
Offering snapshot reported Sep 18, 2024 · SEC filing
- Reported sold
- $2.25M Offering amount: $2.25M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 17, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2024 | Initial | $2,249,998 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-524342
Source: Form D, filed Sep 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Clark | Director |
| Joss Fernandez | Director, Executive |
| Brian Kinman | Director |
| Robert Mills | Director, Executive |
| David Smoller | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4340 Duncan Ave.
St. Louis, MO, 63110
St. Louis, MO, 63110